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Abstract
After many years of controversy, there is now recent and solid evidence that classical Borna disease virus 1 (BoDV-1) can 
infect humans. On the basis of six brain autopsies, we provide the first systematic overview on BoDV-1 tissue distribution 
and the lesion pattern in fatal BoDV-1-induced encephalitis. All brains revealed a non-purulent, lymphocytic sclerosing 
panencephalomyelitis with detection of BoDV-1-typical eosinophilic, spherical intranuclear Joest–Degen inclusion bodies. 
While the composition of histopathological changes was constant, the inflammatory distribution pattern varied interindividu-
ally, affecting predominantly the basal nuclei in two patients, hippocampus in one patient, whereas two patients showed a 
more diffuse distribution. By immunohistochemistry and RNA in situ hybridization, BoDV-1 was detected in all examined 
brain tissue samples. Furthermore, infection of the peripheral nervous system was observed. This study aims at raising 
awareness to human bornavirus encephalitis as differential diagnosis in lymphocytic sclerosing panencephalomyelitis. A 
higher attention to human BoDV-1 infection by health professionals may likely increase the detection of more cases and 
foster a clearer picture of the disease.
Keywords Virus · Bornavirus · Borna disease virus (BoDV-1) · Zoonosis · Encephalitis
Introduction
The classical Borna disease virus 1 (BoDV-1; species Mam-
malian 1 orthobornavirus) can lead to lethal infections in a 
broad range of mammals. The virus is endemically present 
in white-toothed bicolored shrews (Crocidura leucodon) [1, 
7, 16], while horses and sheep are main accidental dead-
end hosts [9]. Historically, a severe neurological disorder 
(Borna disease) due to an encephalomyelitis lymphocytaria 
non-purulenta with loss of neurons had been described for 
accidental hosts [18]. It is assumed that the virus enters the 
organism via the olfactory network and spreads through the 
limbic system to nearly all cortical areas, brainstem, cer-
ebellum, and spinal cord [9]. In contrast to dead-end hosts, 
reservoir hosts feature a disseminated virus distribution to 
nearly every organ with shedding of infectious virus [24]. 
Other animals, including rats and bank voles, can be infected 
experimentally via different routes [10, 19]. Until recently, 
no report on confirmed human bornavirus infection existed. 
In 2015, the first human infections with another orthobor-
navirus (variegated squirrel 1 bornavirus [VSBV-1]; spe-
cies Mammalian 2 orthobornavirus) were described, which 
resulted in lethal encephalitis of three breeders of variegated 
squirrels (Sciurus variegatoides). All three patients showed 
similar central nervous system (CNS) symptoms with 
lesions in cerebral cortex, basal nuclei, and brainstem, but 
without involvement of the spinal cord [17]. Subsequently, 
two more VSBV-1-induced human encephalitis cases 
occurred, whereof one was lethal [32, 33]. The first evidence 
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for human infections with the “classical” BoDV-1 was pub-
lished by two simultaneous reports just recently in 2018. A 
group of three recipients of solid organ transplants from the 
same donor developed severe encephalitis of preliminary 
unknown origin, which was later convincingly demonstrated 
to be BoDV-1-associated [28]. Furthermore, BoDV-1 infec-
tion led to the death of a previously healthy 25-year-old man 
[21]. Shortly afterwards, a report on a sporadic BoDV-1 
infection with initial symptoms mimicking a Guillain–Barré 
syndrome was reported [5]. All five patients suffered a mas-
sive non-purulent encephalitis leading to death in four of the 
cases [5, 21, 28]. One of the deceased immunocompromised 
transplant recipients was autopsied and provided full insight 
into CNS and peripheral nerve pathology (patient 1). This 
incident triggered a broad research on post mortem cases 
with yet non-classified encephalitis. Our screening revealed 
autoptic material of five additional cases of fatal human 
BoDV-1. All patients had appeared completely healthy prior 
to the neurologic disease.
With these six cases, our study provides the first com-
prehensive description of the neuropathology of human 
BoDV-1 infection with focus on inflammatory lesions and 
virus distribution patterns at a systemic and cellular level.
Materials and methods
This retrospective study was approved by the local ethi-
cal committee of the Technical University Munich. The 
families of patients 1, 2, and 6 gave informed consent to 
complete autopsy, whereas the families of patients 3, 4, 
and 5 agreed to brain autopsy only. For patients 1, 2, and 
6, macroscopic evaluation of the thoracic and abdominal 
cavity, including evaluation of all organs, was conducted 
by two pathologists. For microscopic analysis, representa-
tive samples from peripheral organs, including heart, lung, 
liver, kidney, trachea, esophagus, stomach, intestine, and 
others were obtained. Brain dissection was carried out by 
two neuropathologists after routine formalin-fixation of the 
undissected brain. For microscopic analysis, representative 
samples from multiple selected regions of the brain and 
spinal cord were retrieved from following areas: frontal, 
parietal and occipital cortex, hippocampus, basal ganglia, 
mesencephalon, pons, medulla oblongata, cerebellum, as 
well as cervical, thoracic and lumbar parts of the spinal 
cord. From patients 1 and 6, peripheral nerves including 
the sciatic nerve and brachial plexus from patient 1, and 
sural and femoral nerve as well as brachial and sacral plexus 
from patient 6 were sampled in addition to the autonomic 
nerve branches attached to visceral organs and tissues. All 
tissue samples were further fixed in 10% buffered formalin 
and, after paraffin embedding, cut into 2 µm-thick sections. 
Subsequently, different stains were performed, including 
hematoxylin and eosin (H&E) stain, Grocott’s methena-
mine silver stain, and periodic acid-Schiff (PAS) stain. We 
conducted an established avidin–biotin complex technique 
for immunohistochemistry (IHC) using the monoclonal 
Bo18 antibody, which is directed against the nucleoprotein 
(N) of BoDV-1 [11], as described previously in animals 
[15, 35]. Furthermore, BoDV-1 RNA in situ hybridization 
(V-BoDV1-G targeting 2-969 of NC_001607-1:2236-3747, 
 RNAscope®, Advanced Cell Diagnostics, Inc., USA) was 
performed as described previously [34]. For patients 1, 2, 3, 
and 5, infiltrating inflammatory cells were characterized by 
IHC using antibodies directed against CD3 (Cell Marque, 
The Netherlands; monoclonal, rabbit, dilution 1:500), CD20 
(Dako Denmark A/S, Denmark; monoclonal, mouse, dilu-
tion 1:500), CD4 (Ventana Roche, Switzerland; monoclonal, 
rabbit, ready-to-use), CD8 (Ventana Roche, Switzerland; 
monoclonal, rabbit, ready-to-use), CD68 (Dako Denmark 
A/S, Denmark; monoclonal, mouse, dilution 1:15,000), 
CD138 (Cell Marque, The Netherlands; monoclonal, mouse, 
dilution 1:50), and Iba1 (abcam, USA; polyclonal, rabbit, 
dilution 1:500). These stainings were performed using 
a fully-automated staining system (Ventana BenchMark 
ULTRA; Ventana Medical Systems; Tucson; USA). Briefly, 
the slides were exposed to heat-induced epitope uncover-
ing in pH 8.4 buffer at 95 °C for 40 min. After incubating 
with  H2O2, the slides were incubated with the primary anti-
bodies indicated above, followed by visualization using the 
3,3′-diaminobenzidine-(DAB-)based OptiView DAB IHC 
Detection Kit (Ventana Medical Systems).
To characterize the cellular distribution of the infection, 
immunolabelling with Bo18 antibody was combined with 
cell markers Iba1 (abcam, USA; polyclonal rabbit, dilution 
1:500), GFAP (Dako Denmark A/S, Denmark; rabbit poly-
clonal, dilution 1:500), S-100 (Dako Denmark A/S, Den-
mark; rabbit polyclonal, 1:500) and synaptophysin (Synaptic 
Systems, Germany; rabbit polyclonal, dilution 1:200) using 
an antibody removal agent (LinBlock, Linaris, Germany) 
and a green second chromogen  (Histogreen®, Linaris, 
Germany).
In the same vein, RNA in situ hybridization of BoDV-1 
RNA (V-BoDV1-G targeting 2-969 of NC_001607-1:2236-
3747,  RNAscope®, Advanced Cell Diagnostics, Inc., USA) 
was performed, followed by immunohistochemical coun-
terstaining with glial fibrillary acidic protein (GFAP; Dako 
Denmark A/S, Denmark; monoclonal, mouse, dilution 
1:500), S-100 (Agilent, USA; polyclonal, rabbit, dilution 
1:6000), myelin basic protein (MBP; Cell Marque Corpora-
tion, USA; polyclonal, rabbit, ready-to-use, dilution 1:2), 
neurofilament (NFpan; Dako Denmark A/S, Denmark; mon-
oclonal, mouse, dilution 1:200), Iba1 (abcam, USA; poly-
clonal, rabbit, dilution 1:500), CD68 (Dako Denmark A/S, 
Denmark; monoclonal, mouse, dilution 1:15.000) and CD3 
(Cell Marque, The Netherlands; monoclonal, rabbit, dilution 
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1:500). BoDV-1-positive horse brain sections were used as 
controls. Lesions and immunohistochemical patterns were 
recorded and mapped for the individual patients.
For ultrastructural analyses, primary formalin-fixed brain 
samples from patient 6 were postfixed with Karnovsky-fixa-
tive (0.1 M cacodylate-buffer with 2.5% glutaraldehyde and 
2% paraformaldehyde), followed by fixation in 1% osmium 
tetroxide at pH 7.3 for 2 h. Afterwards, they were dehydrated 
in graded ethanols, and embedded in the EMbed-812 epoxy 
resin (all reagents from Science Services, Germany; auto-
mated LYNX-tissue processor Leica, Germany). After 48 h 
of heat polymerisation at 60° C, semithin (0.8 µm) sections 
were cut and stained with toluidine blue and basic fuchsin. 
Light microscopy was used for selection of representative 
cells and ultrathin (80 nm) sections were cut with a diamond 
knife on a Reichert Ultracut-S ultramicrotome (Leica, Ger-
many) and double stained with aqueous 2% uranyl acetate 
and lead citrate solutions for 10 min each. The sections were 
examined in a LEO912AB electron microscope (Zeiss, Ger-
many) operating at 100 kV, equipped with a side-mounted 
CCD-camera (TRS, Lagerlechfeld / Germany) capable to 
record images with 2kx2k pixels. Documentation was done 
with the iTEM software (Olympus Soft Imaging Solutions 
GmbH, Germany).
For all six patients, the presence of BoDV-1 RNA in 
the brain was confirmed by reverse transcriptase quantita-
tive polymerase chain reaction (RT-qPCR) and complete 




The six patients were all female and between 13 and 78 years 
of age (median 38 years). Five patients were apparently 
healthy prior to neurological disease, without any signs of 
immunodeficiency. One patient (patient 1) was therapeuti-
cally immunosuppressed after kidney transplantation [28].
Initially, four patients developed flu-like symptoms, 
including fever, followed by neurological signs, which pro-
gressed to loss of consciousness. One patient presented with 
right-sided weakness and unsteady gait. Death of the five 
previously healthy patients occurred between 2 and 6 weeks 
after admission to the hospital. The immunosuppressed 
patient 1 developed a severe axonal motor neuropathy with 
Guillain–Barré syndrome-like spread on post-transplant day 
80. Symptoms progressed to tetraplegia and deficit of all cra-
nial nerves, followed by persistent coma and death 14 weeks 
after initial symptoms. For detailed clinical presentation, see 
Table 1.
Findings of the general organ autopsies
General autopsy of patient 1 revealed signs of multiple organ 
failure. Both autologous kidneys displayed high-grade atro-
phy with underlying mesangioproliferative glomerulone-
phritis. The transplanted kidney revealed no clear signs of 
rejection, but showed numerous nodular lymphocytic infil-
trates, containing CD20- and CD3-positive cells, whereof 
the latter were composed of approximately equal propor-
tions of CD4- and CD8-positive cells. Underlying diseases 
including atherosclerosis of aorta and coronary vessels plus 
myocardial hypertrophy and fibrosis as well as chronic pul-
monary emphysema but no signs of a clinically suspected 
pneumonia were observed.
General autopsy of patient 2 revealed massive pulmo-
nary edema and acute pulmonary congestion with consecu-
tive acute biventricular cardiac dilation. Except for signs of 
shock, the other organs were without pathological findings. 
Likewise, in case of patient 6, no signs of inflammation were 
seen in the peripheral organs.
General autopsies were not conducted for the remaining 
patients, as the families gave consent to brain autopsy only.
Macroscopic examination of the CNS
Macroscopically, the brain of patient 1 showed a consider-
able increase in volume with softened texture. Transtentorial 
as well as tonsillar herniation was observed on both sides. 
Coronal brain dissection revealed livid discoloration of the 
cerebral cortex with areas of an indefinite cortico-medullary 
junction. The ventricular system appeared constricted at full-
length but without midline shift. Cerebellum, brain stem, 
and spinal cord were increased in volume, too. The brain 
of patient 2 appeared macroscopically unremarkable. In the 
brain of patient 3, the basal nuclei were softened on both 
sides. Globally, the brain of patient 4 appeared softened with 
mild edema. Incipient tonsillar herniation was noted. After 
coronal dissection, the cerebral and cerebellar tissue were 
of softened texture with accentuation of the cortical areas. 
The brain of patient 5 appeared edematous with discretely 
prominent cerebellar tonsils but without distinct tonsillar 
herniation. After coronal brain dissection, the ventricular 
system was slightly constricted but without any midline 
shift. Malacia of the hippocampal region was noted on both 
sides. The brain of patient 6 showed uncal herniation on 
the left side, but without considerable compression of the 
midbrain. Coronal sections of the cerebrum displayed slight 
edema of the subcortical white matter.
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Microscopic examination of the CNS and PNS
Cerebral tissue of all six patients exhibited a non-purulent 
panencephalomyelitis with edematous and spongy texture 
as well as perivasculary accentuated infiltration of lympho-
cytes (Fig. 1a). The number of diffusely infiltrating lympho-
cytes was highest in patient 1, followed by patients 4 and 5, 
whereas the remaining patients showed substantially lower 
numbers. Even though lymphocytic infiltrates were found in 
all examined samples, the inflammation was accentuated in 
the basal nuclei of patients 3 and 4 and hippocampal area of 
patient 5. In the CNS of patient 6, inflammation was mostly 
pronounced in the upper brain stem and subcortical nuclei. 
The brains of patients 1 and 2 showed a more global diffuse 
infiltration with no clear accentuation. Diffusely distributed 
macrophages, filled with eosinophilic, PAS-positive mate-
rial, and plasma cells were observed most prominently in 
patient 1. Beyond formation of microglial nodules, all brains 
demonstrated distinct astrogliosis with remarkably enlarged 
reactive astrocytes exhibiting enlarged nuclei with thin and 
marginal chromatin and opaque-eosinophilic cytoplasm 
(Fig. 1c). In patient 1, global malacia with tremendous loss 
of neurons with remaining nuclear debris was observed. 
In patient 4, severe malacia was noted in the hippocampus 
and in the cortex of frontal and occipital lobe. The loss of 
neurons was less pronounced in the brains of the remain-
ing patients. In all patients, neurons and astrocytes showed 
eosinophilic, spherical, intranuclear inclusions without clear 
halo, so-called Joest–Degen inclusion bodies (Fig. 1b).
The majority of infiltrating lymphocytes were CD3-pos-
itive (Fig. 1d), with more CD4-positive than CD8-positive 
cells. Furthermore, IHC revealed numerous CD68-positive 
macrophages and strong microglial (Fig. 1e) and glial acti-
vation, demonstrated by Iba1 and GFAP immunostaining.
Fig. 1  Microscopic changes in human Borna disease. a H&E shows 
perivascular accentuated (arrow) and diffuse distributed lymphocytic 
infiltrates, microglial nodules (star) and a distinct reactive astroglio-
sis Scale bar: 50 µm, basal nuclei, patient 1. b H&E reveals intranu-
clear, eosinophilic inclusions (arrows), known as Joest–Degen bodies 
in a reactive astrocyte. Scale bar: 10  µm, cortex, patient 2. c H&E 
shows distinct astrogliosis with remarkably enlarged reactive astro-
cytes exhibiting enlarged nuclei with thin and marginal chromatin and 
opaque-eosinophilic cytoplasm. Scale bar: 20 µm, cortex, patient 4. d 
CD3 immunohistochemistry shows the lymphocytic distribution with 
perivascular accentuation as well as diffuse parenchymal infiltration. 
Scale bar: 100 µm, hippocampal, patient 2. e Iba1 immunohistochem-
istry confirms strong activation of the microglia and macrophages. 
Scale bar: 100 µm, basal nuclei, patient 3. f Bo18 immunohistochem-
istry indicates virus infestation of neurons with distinct positivity of 
axons with nodular protuberance (arrows). Scale bar: 10  µm, pons, 
patient 2. g Virus protein detection by Bo18 immunohistochemistry 
in a small nerve in the surrounding tissue of the esophagus. Scale 
bar: 20 µm, patient 1. h Bo18 immunohistochemistry of the pituitary 
gland with strong positivity of the posterior pituitary (white star) but 
no detection of virus protein in the adenohypophysis (black star). 
Scale bar: 50 µm, pituitary gland, patient 2. i Virus protein detection 
by Bo18 immunohistochemistry in the sciatic nerve; dense lympho-
cytic infiltrates (arrow). Scale bar: 20 µm, sciatic nerve, patient 1
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Brain stems and spinal cords displayed inflammatory 
changes as well whereas the cerebella were milder affected. 
Here, a global, almost complete loss of Purkinje cells with 
Bergmann glia proliferation was observed in patients 1, 2, 
4, and 6, which was considerably milder in patients 3 and 5.
Sections of peripheral nerves of patient 1 showed massive 
necrotizing lymphocytic neuritis (Fig. 1i) with CD4- and 
predominantly CD8-positive lymphocytes. Small nerves of 
peripheral organs in patients 1 and 2 appeared inconspicu-
ous, though.
For local distribution of lymphocytic infiltration, micro-
glial activation, edematous, and hypoxic changes, see 
Table 2 and Fig. 2.
Immunohistochemistry of BoDV‑1 nucleoprotein 
and BoDV‑1 RNA in situ hybridization
BoDV-1 nucleoprotein and RNA were detected in all exam-
ined CNS tissue samples including the spinal cord of all 
six patients, with less BoDV-1-positive cells detectable 
in the brain of patient 3 as compared to all other patients. 
Immunoreaction and RNA signal were present in neuronal 
cells, astrocytes, and oligodendrocytes. The neurons showed 
somatic as well as axonal and dendritic positivity (Figs. 1f, 
3a).
Patient 1 showed a strong diffuse BoDV-1 distribution in 
all examined samples of cerebrum, cerebellum, and brain 
stem without clear focal accentuation. A uniform distribu-
tion of BoDV-1-positive cells was seen in patient 2, but with 
a smaller number of positive cells. Patients 3 and 4 showed 
a distinct accentuation of viral presence in the basal nuclei, 
primarily in neuronal, less in glial cells. In patient 4, samples 
of frontal, parietal, and occipital cortex and white matter 
showed a strong positivity in subcortical reactive astrocytes 
with only a small number of positive neurons and cortical 
glial cells. In patient 5, an accentuation of BoDV-1-positive 
neurons was noted in the hippocampal area on both sides. 
Interestingly, the occipital lobe showed a clearly lower num-
ber of BoDV-1-positive neurons and glial cells compared 
to other cortical and subcortical locations. In patient 6, the 
strongest immunoreaction was observed in the samples of 
the mesencephalon, cerebellum, and hippocampal region. 
Interestingly, the cortex of the occipital lobe showed a strong 
immunoreaction in the neurons as well as in the glial cells, 
whereas glial cells of the subcortical white matter were com-
pletely BoDV-1-negative. In all patients, the ependymal cells 
were partially BoDV-1-positive (Fig. 3b). For cerebral virus 
distribution, see also Fig. 2.
The pituitary gland of patient 2 showed a strong immuno-
reaction and RNA signal of the posterior pituitary compared 
to absence of BoDV-1 in the adenohypophysis (Fig. 1h) 
demonstrating the strong neurotropism of BoDV-1 in acci-
dental dead-end hosts.
Furthermore, a positive immunoreaction and detection 
of BoDV-1 RNA were observed in all examined peripheral 
nerves of patient 1 (Figs. 1i, 3c). Diminutive nerves of vis-
ceral organs were BoDV-1-positive in both tested patients, 
including trachea and esophagus of patient 1 (Fig. 1g) and 
adrenal gland and thyroid gland of patient 2. No viral antigen 
or RNA was detected in the parenchyma and endothelial 
cells of visceral organs, though.
Co‑staining of BoDV‑1 nucleoprotein and RNA 
with cellular markers
To determine the cell types infected by BoDV-1, co-stain-
ing for the BoDV-1 nucleoprotein with either GFAP, syn-
aptophysin, or S-100 was performed. In the CNS, BoDV-1 
antigen was detected in synaptophysin-positive neurons 
and GFAP-positive astrocytes. In the PNS, S-100-positive 
Schwann cells were strongly positive for BoDV-1 antigen.
These observations were corroborated by BoDV-1 RNA 
in situ hybridization combined with IHC. NFpan-positive 
neurons (Fig. 3d), as well as GFAP-positive reactive astro-
cytes (Fig. 3e) and MBP-positive oligodendrocytes (Fig. 3f) 
showed strong BoDV-1 RNA signal. No RNA signal was 
seen in microglial cells (Fig. 3g), macrophages (Fig. 3h) and 
lymphocytes (Fig. 3i). In the PNS, viral RNA was associ-
ated with NFpan-positive axons and S-100-positive Schwann 
cells.
Electron microscopy
Transmission electron microscopy (TEM) of neocortical, 
subcortical, and brainstem specimens of patient 6 showed 
perivascular accentuated lymphomonocytic inflammation at 
low magnification. Intranuclear inclusions were predomi-
nantly seen in astrocytes and oligodendrocytes (Fig. 4a, c). 
Higher magnification of these inclusions revealed concen-
tric complexes of membranous structures, the architecture 
characteristic of viral RNA replication centers (Fig. 4b, d).
Discussion
Numerous descriptions of the neuropathological findings 
of BoDV-1 encephalitis in naturally infected animals have 
been published since 1911 when Joest and Degen gave the 
first report on Borna disease in horses [18]. Nevertheless, a 
detailed neuropathological depiction of BoDV-1 infection 
in humans is missing so far, as human bornavirus infections 
were confirmed only recently in VSBV-1-infected breed-
ers and animal care takers of exotic squirrels [17, 32, 33] 
and in BoDV-1-infected patients, including three recipients 
of organ transplants from the same donor [5, 21, 28]. All 
patients had developed encephalitis and neurologic disease 
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resembling Borna disease in horses and sheep, which had 
been fatal in most cases [5, 17, 21, 28, 32, 33]. One organ 
recipient was autopsied at our institute and gave for the first 
time deeper insights into human BoDV-1 encephalitis [28].
Through BoDV-1 screening of current post mortem cases 
with yet non-classified encephalitis, autoptic material of five 
additional sporadic cases of fatal BoDV-1 infection was 
detected. With a series of six cases, we are now able to give 
a first detailed and systematic description of the neuropatho-
logical findings in human BoDV-1 infection.
All brains featured similarities in their histopathologi-
cal appearance, which can be summarized as lymphocytic 
sclerosing panencephalomyelitis with strong formation 
of microglial nodules. With co-staining of BoDV-1 RNA 
in  situ hybridization and cellular markers, infected cell 
types including neurons, astrocytes, and oligodendrocytes 
were identified. In contrast, microglial cells as well as mac-
rophages and lymphocytes were not infected. In neurons, 
BoDV-1 was detected in cell bodies as well as neuritic 
and dendritic processes. Furthermore, in all patients, the 
so-called Joest–Degen inclusion bodies were found. Due 
to their morphology, these intranuclear inclusions are 
accounted among Cowdry-type B inclusions [6, 18, 26].
Even if the histopathological aspects were consistent in 
all patients, they are not specific for bornavirus encepha-
litis, though, as other virus encephalitides exhibit similar 
appearances [4, 8]. Perivascularly accentuated lymphocytic 
infiltrates, together with glial and microglial activation is 
often found in arbovirus infections including tick-borne 
encephalitis [8]. Nevertheless, nuclear inclusion bodies as 
seen in all BoDV-1-infected patients have not been described 
for tick-borne encephalitis and might be a helpful distinc-
tive criterion. It should be noted that Southern Germany, 
the home area of all patients of this study, is an endemic 
region for both, tick-borne encephalitis virus and BoDV-1 
[14, 20]. Furthermore, the strong sclerosing aspect due 
Fig. 2  Interindividual dif-
ferences of human BoDV-1 
encephalitis. Schematic 
illustration of inflammatory 
changes (left side, blue) and 
virus antigen distribution (right 
side, brown) of all six patients 
with coronar sections including 
a level through the mammillary 
bodies with the basal nuclei 
(a), the occipital lobe (b), the 
cerebellum (c), and midbrain 
(d). Blue areas demonstrate dif-
fuse parenchymal lymphohistio-
cytic infiltrates, while blue dots 
represent perivascular cuffs. 
Diffuse somatic and neuritic 
immunopositivity is illustrated 
by brown areas. Small groups 
of immunopositive neurons 
are demonstrated by brown 
triangles, groups of immunopo-
sitive astrocytes by brown star-
like figures. Note the distinct 
enhancement of inflammation in 
the basal nuclei of patient 3
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to glial activation together with perivascular accentuated 
inflammatory infiltrates as seen in bornavirus encephalitis 
might resemble subacute sclerosing panencephalitis (SSPE) 
as secondary manifestation of measles virus infection [4]. 
Although the clinical aspects of SSPE usually differ from the 
described courses of BoDV-1 infection, bornaviruses should 
be considered as possible differential diagnoses.
In contrast to the constancy of the histopathological 
changes, interindividual differences regarding the distri-
bution patterns of viral antigens and inflammatory infil-
trates were observes. Two patients showed accentuation of 
lymphocytes in the basal nuclei, whereas in one patient, 
the hippocampal area and in another the upper brain stem 
were primarily affected. Two patients, however, showed 
a more uniform distribution including the grey as well 
as the white matter without clear local accentuation. It 
should be noted, however, that the described distribution 
patterns reflect the end-stage pathology after terminal 
disease. Nevertheless, accentuations might indicate pri-
marily affected sites that may be targeted by diagnostic 
biopsy testing. All five previously healthy patients devel-
oped central neurological deficits early in the course of 
disease, whereas peripheral symptoms were not pre-
dominant. In contrast, the immunocompromised patient 
1 developed initial symptoms mimicking Guillain–Barré 
syndrome, which is in line with BoDV-1 infection and 
inflammation observed in the PNS of this patient. Similar 
symptomology had been described for the second kidney 
recipient [28] and a recently published previously healthy 
BoDV-1-infected patient [5]. Furthermore, small nerves 
of peripheral organs of patients 1 and 2, including trachea 
and esophagus, were BoDV-1-positive. Infectious neu-
ropathies have been described for other viruses, including 
hepatitis C virus and several herpesviruses, but are very 
rare incidents and occur only in a rather late course of 
the virus infections [2]. For patient 1, though, the neuritis 
was an early event, given the development of peripheral 
symptoms before any signs of CNS affection. Infection 
of the PNS has already been observed in experimen-
tally BoDV-1-infected animals [19]. For human VSBV-1 
Fig. 3  RNA in  situ hybridization and co-stainings. a RNA in  situ 
hybridization shows red signal for virus RNA in neurons and glial 
cells. A pyramidic cell shows virus RNA in dendrites (black arrows), 
including small dendritic branches (white arrows). Scale bar: 10 µm, 
cortical, patient 2. b RNA in situ hybridization indicates virus infesta-
tion of ependymal cells. Scale bar: 10 µm, patient 4. c RNA in  situ 
hybridization detects BoDV1 in peripheral nerves. Scale bar: 10 µm, 
sciatic nerve, patient 1. Co-stainings of RNA in  situ hybridization 
and immunohistochemical cellular markers show BoDV-1 RNA in 
NFpan-positive neurons (d, arrows), GFAP-positive reactive astro-
cytes (e, arrows) and MBP-positive oligodendrocytes (f, arrows point 
at MBP-positive processes). In contrast, Iba1-positive microglial cells 
(g, arrows), CD68-positive macrophages (h, arrow points at perivas-
cular located macrophages) and CD3-positive lymphocytes (i black 
arrow points at perivascular located lymphocytes, white arrow at dif-
fusely distributed lymphocytes) show no virus infestation. Scale bars: 
10 µm; d, g, i cortical, patient 2, e hippocampal, patient 4, f, h corti-
cal, patient 5
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infection, no PNS infection was described; the spinal cord 
showed no affection either [17, 32, 33]. Naturally BoDV-
1-infected accidental animal hosts, including horses and 
sheep, rarely show signs of PNS infection [9]. In contrast, 
reservoir hosts, such as BoDV-1-infected bicolored white-
toothed shrews or VSBV-1-infected squirrels, harbor the 
virus not only in central and peripheral nervous tissue, 
but also in non-neuronal cells including mesenchymal and 
epithelial cells of nearly every organ system, e.g., the res-
piratory and urinary tracts. However, bornavirus-induced 
inflammation is not observed in these hosts [7, 24, 27, 
29]. Infectious virus can be detected in several excretions 
of BoDV-1-infected shrews, including saliva, urine, and 
feces [24], which is assumed to infect horses and possibly 
other accidental hosts via an olfactory route [23], followed 
by a spread to the limbic system [9]. This may explain 
the primary affection of these phylogenetically older areas 
of the CNS in horses [10, 22]. For humans, the route of 
entry has not been clarified, yet. Only for patient 1, the 
infected kidney transplant was confirmed as the source 
of infection, since retrospectively, the donor was retro-
spectively proven to be seropositive for BoDV-1, all three 
organ recipients suffered from bornavirus encephalitis, and 
identical viral sequences were found in the brains of both 
kidney recipients [28]. A significant accentuation of the 
limbic system indicating an olfactory route, as described 
for horses [10, 22] was observed only in patient 5, whereas 
patients 3 and 4 revealed a strong accentuation of the basal 
nuclei.
Interestingly, the course of disease was prolongated in 
patient 1 compared to the other patients (14 weeks com-
pared to 2–6 weeks). The cytotoxicity in BoDV-1 infection 
is known to be mediated by BoDV-1-specific CD8-positive T 
lymphocytes [3, 13, 30]. Thus, therapeutic immunosuppres-
sion after kidney transplantation might have decelerated the 
course of disease in patient 1 and might give lead to thera-
peutic possibilities. T-lymphocyte depletion or suppression 
starting before or early after experimental BoDV-1 infection 
was demonstrated to prevent immunopathology in rodent 
models [12, 25, 31].
The strong interindividual differences lead to several 
intriguing questions including infections routes, dose of 
infectious virus, the impact of the duration of infection, 
susceptibility, and potential risk factors. Here, we present 
the first comprehensive description on the neuropathology 
of human victims of bornavirus encephalitis. Our report is 
based on only six autopsies since the first confirmed human 
BoDV-1 infections appeared just recently [5, 21, 28]. Our 
Fig. 4  Electron microscopy 
of subcortical white matter 
of patient 6. a, c Low resolu-
tion shows astrocytic nuclei 
containing concentric structures 
(arrows). Scale bar a 2 µm 
(× 10,000), scale bar c 5 µm 
(× 5000). b, d High power 
views of a and c insets (areas 
within rectangles) display 
detailed architecture of viral 
replication centers (arrows). 
Scale bar b 1 µm (× 25,000), 
scale bar d 500 nm (× 40,000)
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data aim to initiate a better understanding of the circum-
stances and pathobiology of human Borna disease that are 
clearly needed to identify so far undiagnosed cases and 
develop an epidemiological basis.
Conclusion
On the basis of six brain autopsies, human BoDV-1 infection 
was shown to result in lymphocytic sclerosing panencepha-
lomyelitis with detection of BoDV-1-typical eosinophilic, 
spherical, intranuclear Joest–Degen inclusion bodies. Bor-
navirus infection should be considered in cases matching 
these characteristics. While the composition of histopatho-
logical changes appears consistent, the lesion distribution 
pattern varies interindividually, which might indicate dif-
ferent routes of entry or individual immune status. Infection 
of the PNS may occur and results in clinical presentation 
resembling Guillain–Barré syndrome in some cases. The 
common and overlapping neuropathological signs we here 
describe will likely stimulate the identification of additional 
cases. These could then be used to gain a clearer depiction of 
locoregional manifestation patterns and to the identification 
of favorable locations for diagnostic biopsies.
Acknowledgements We would like to thank S. Baur, Ch. Schustetter, 
K. Stingl, and P. Meyer for their excellent technical assistance as well 
as G. Weirich and C. Delbridge for professional conduction of general 
and brain autopsy. We also thank J. A. Schroeder for his very help-
ful advice regarding the evaluation of ultrastructural tissue analysis. 
This work was partly supported by Grants from the German Federal 
Ministry of Education and Research within the research consortium 
“ZooBoCo” (Grant no. 01KI1722A).
Compliance with ethical standards 
Conflict of interest All authors declare that there are no conflicts of 
interest.
Ethical approval This retrospective study was approved by the local 
ethical committee of the Technical University Munich.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. Bourg M, Herzog S, Encarnacao JA, Nobach D, Lange-Herbst H, 
Eickmann M, Herden C (2013) Bicolored white-toothed shrews as 
reservoir for borna disease virus, Bavaria, Germany. Emerg Infect 
Dis 19(12):2064–2066. https ://doi.org/10.3201/eid19 12.13107 6
 2. Brizzi KT, Lyons JL (2014) Peripheral nervous system manifesta-
tions of infectious diseases. Neurohospitalist 4(4):230–240. https 
://doi.org/10.1177/19418 74414 53521 5
 3. Chevalier G, Suberbielle E, Monnet C, Duplan V, Martin-Blondel 
G, Farrugia F, Le Masson G, Liblau R, Gonzalez-Dunia D (2011) 
Neurons are MHC class I-dependent targets for CD8 T cells upon 
neurotropic viral infection. PLoS Pathog 7(11):e1002393. https ://
doi.org/10.1371/journ al.ppat.10023 93
 4. Cole AJ, Henson JW, Roehrl MH, Frosch MP (2007) Case records 
of the Massachusetts General Hospital. Case 24-2007. A 20-year-
old pregnant woman with altered mental status. N Engl J Med 
357(6):589–600. https ://doi.org/10.1056/NEJMc pc079 018
 5. Coras R, Korn K, Kuerten S, Huttner HB, Ensser A (2019) Severe 
bornavirus-encephalitis presenting as Guillain-Barre-syndrome. 
Acta Neuropathol 137(6):1017–1019. https ://doi.org/10.1007/
s0040 1-019-02005 -z
 6. Cowdry EV (1934) The problem of intranuclear inclusions in 
virus diseases. Arch Pathol 18:527–542
 7. Durrwald R, Kolodziejek J, Weissenbock H, Nowotny N (2014) 
The bicolored white-toothed shrew Crocidura leucodon (HER-
MANN 1780) is an indigenous host of mammalian Borna disease 
virus. PLoS O ne 9(Pt 4):e93659. https ://doi.org/10.1371/journ 
al.pone.00936 59
 8. Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka 
H (2005) Visualization of Central European tick-borne encepha-
litis infection in fatal human cases. J Neuropathol Exp Neurol 
64(6):506–512. https ://doi.org/10.1093/jnen/64.6.506
 9. Gosztonyi G (2008) Natural and experimental Borna disease virus 
infections—neuropathology and pathogenetic considerations. 
APMIS Suppl 116(124):53–57
 10. Gosztonyi G, Ludwig H (1995) Borna disease—neuropathology 
and pathogenesis. Curr Top Microbiol Immunol 190:39–73
 11. Haas B, Becht H, Rott R (1986) Purification and properties of 
an intranuclear virus-specific antigen from tissue infected with 
Borna disease virus. J Gen Virol 67(2):235–241. https ://doi.
org/10.1099/0022-1317-67-2-235
 12. Hallensleben W, Schwemmle M, Hausmann J, Stitz L, Volk B, 
Pagenstecher A, Staeheli P (1998) Borna disease virus-induced 
neurological disorder in mice: infection of neonates results in 
immunopathology. J Virol 72(5):4379–4386
 13. Hausmann J, Hallensleben W, de la Torre JC, Pagenstecher A, 
Zimmermann C, Pircher H, Staeheli P (1999) T cell ignorance 
in mice to Borna disease virus can be overcome by peripheral 
expression of the viral nucleoprotein. Proc Natl Acad Sci USA 
96(17):9769–9774
 14. Hellenbrand W, Kreusch T, Bohmer MM, Wagner-Wiening C, 
Dobler G, Wichmann O, Altmann D (2019) Epidemiology of 
Tick–Borne encephalitis (TBE) in Germany, 2001(–)2018. Patho-
gens 8:2. https ://doi.org/10.3390/patho gens8 02004 2
 15. Herden C, Schluesener HJ, Richt JA (2005) Expression of allo-
graft inflammatory factor-1 and haeme oxygenase-1 in brains of 
rats infected with the neurotropic Borna disease virus. Neuro-
pathol Appl Neurobiol 31(5):512–521. https ://doi.org/10.111
1/j.1365-2990.2005.00668 .x
 16. Hilbe M, Herrsche R, Kolodziejek J, Nowotny N, Zlinszky K, 
Ehrensperger F (2006) Shrews as reservoir hosts of Borna disease 
virus. Emerg Infect Dis 12(4):675–677. https ://doi.org/10.3201/
eid12 04.05141 8
 17. Hoffmann B, Tappe D, Hoper D, Herden C, Boldt A, Mawrin C, 
Niederstrasser O, Muller T, Jenckel M, van der Grinten E, Lutter 
C, Abendroth B, Teifke JP, Cadar D, Schmidt-Chanasit J, Ulrich 
RG, Beer M (2015) A variegated squirrel bornavirus associated 
with fatal human encephalitis. N Engl J Med 373(2):154–162. 
https ://doi.org/10.1056/NEJMo a1415 627
 18. Joest E, Degen K (1911) Untersuchungen über die pathologis-
che Histologie, Pathogenese und postmortale Diagnose der 
664 Acta Neuropathologica (2019) 138:653–665
1 3
seuchenhaften Gehirn-Rückenmarksentzündung (Bornaschen 
Krankheit) des Pferdes. Z Infkrkh Haustiere 9:1–98
 19. Kinnunen PM, Inkeroinen H, Ilander M, Kallio ER, Heikkila HP, 
Koskela E, Mappes T, Palva A, Vaheri A, Kipar A, Vapalahti 
O (2011) Intracerebral Borna disease virus infection of bank 
voles leading to peripheral spread and reverse transcription of 
viral RNA. PLoS O ne 6(8):e23622. https ://doi.org/10.1371/journ 
al.pone.00236 22
 20. Kolodziejek J, Durrwald R, Herzog S, Ehrensperger F, Lussy H, 
Nowotny N (2005) Genetic clustering of Borna disease virus natu-
ral animal isolates, laboratory and vaccine strains strongly reflects 
their regional geographical origin. J Gen Virol 86(Pt 2):385–398. 
https ://doi.org/10.1099/vir.0.80587 -0
 21. Korn K, Coras R, Bobinger T, Herzog SM, Lucking H, Stohr 
R, Huttner HB, Hartmann A, Ensser A (2018) Fatal encepha-
litis associated with Borna disease virus 1. N Engl J Med 
379(14):1375–1377. https ://doi.org/10.1056/NEJMc 18007 24
 22. Ludwig H (2008) The biology of bornavirus. APMIS Suppl 
116(124):14–20
 23. Morales JA, Herzog S, Kompter C, Frese K, Rott R (1988) Axonal 
transport of Borna disease virus along olfactory pathways in spon-
taneously and experimentally infected rats. Med Microbiol Immu-
nol 177(2):51–68
 24. Nobach D, Bourg M, Herzog S, Lange-Herbst H, Encarnacao JA, 
Eickmann M, Herden C (2015) Shedding of infectious Borna dis-
ease virus-1 in living bicolored white-toothed shrews. PLoS O ne 
10(8):e0137018. https ://doi.org/10.1371/journ al.pone.01370 18
 25. Noske K, Bilzer T, Planz O, Stitz L (1998) Virus-specific CD4+ 
T cells eliminate borna disease virus from the brain via induction 
of cytotoxic CD8+ T cells. J Virol 72(5):4387–4395
 26. Pospischil A (1981) Comparative light and electron microscopic 
demonstration of virus-induced inclusion bodies. Zentralbl Vet-
erinarmed B 28(9–10):789–807
 27. Puorger ME, Hilbe M, Muller JP, Kolodziejek J, Nowotny N, 
Zlinszky K, Ehrensperger F (2010) Distribution of Borna disease 
virus antigen and RNA in tissues of naturally infected bicolored 
white-toothed shrews, Crocidura leucodon, supporting their role 
as reservoir host species. Vet Pathol 47(2):236–244. https ://doi.
org/10.1177/03009 85809 35184 9
 28. Schlottau K, Forth L, Angstwurm K, Hoper D, Zecher D, Liesche 
F, Hoffmann B, Kegel V, Seehofer D, Platen S, Salzberger B, 
Liebert UG, Niller HH, Schmidt B, Matiasek K, Riemenschneider 
MJ, Brochhausen C, Banas B, Renders L, Moog P, Wunderlich S, 
Seifert CL, Barreiros A, Rahmel A, Weiss J, Tappe D, Herden C, 
Schmidt-Chanasit J, Schwemmle M, Rubbenstroth D, Schlegel J, 
Pietsch C, Hoffmann D, Jantsch J, Beer M (2018) Fatal encepha-
litic Borna disease virus 1 in solid-organ transplant recipients. N 
Engl J Med 379(14):1377–1379. https ://doi.org/10.1056/NEJMc 
18031 15
 29. Schlottau K, Jenckel M, van den Brand J, Fast C, Herden C, Hoper 
D, Homeier-Bachmann T, Thielebein J, Mensing N, Diender B, 
Hoffmann D, Ulrich RG, Mettenleiter TC, Koopmans M, Tappe 
D, Schmidt-Chanasit J, Reusken CB, Beer M, Hoffmann B 
(2017) Variegated squirrel bornavirus 1 in squirrels, Germany 
and the Netherlands. Emerg Infect Dis 23(3):477–481. https ://doi.
org/10.3201/eid23 03.16106 1
 30. Stitz L, Planz O, Bilzer T, Frei K, Fontana A (1991) Transform-
ing growth factor-beta modulates T cell-mediated encepha-
litis caused by Borna disease virus. Pathogenic importance of 
CD8+ cells and suppression of antibody formation. J Immunol 
147(10):3581–3586
 31. Stitz L, Sobbe M, Bilzer T (1992) Preventive effects of early 
anti-CD4 or anti-CD8 treatment on Borna disease in rats. J Virol 
66(6):3316–3323
 32. Tappe D, Frank C, Homeier-Bachmann T, Wilking H, Allendorf 
V, Schlottau K, Munoz-Fontela C, Rottstegge M, Port JR, Rissland 
J, Eisermann P, Beer M, Schmidt-Chanasit J (2019) Analysis of 
exotic squirrel trade and detection of human infections with varie-
gated squirrel bornavirus 1, Germany, 2005 to 2018. Euro Surveill 
24:8. https ://doi.org/10.2807/1560-7917.ES.2019.24.8.18004 83
 33. Tappe D, Schlottau K, Cadar D, Hoffmann B, Balke L, Bewig 
B, Hoffmann D, Eisermann P, Fickenscher H, Krumbholz A, 
Laufs H, Huhndorf M, Rosenthal M, Schulz-Schaeffer W, Ismer 
G, Hotop SK, Bronstrup M, Ott A, Schmidt-Chanasit J, Beer M 
(2018) Occupation-associated fatal limbic encephalitis caused by 
variegated squirrel bornavirus 1, Germany, 2013. Emerg Infect 
Dis 24(6):978–987. https ://doi.org/10.3201/eid24 06.17202 7
 34. Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo 
HT, Ma XJ, Luo Y (2012) RNAscope: a novel in situ RNA analy-
sis platform for formalin-fixed, paraffin-embedded tissues. J Mol 
Diagn 14(1):22–29. https ://doi.org/10.1016/j.jmold x.2011.08.002
 35. Werner-Keiss N, Garten W, Richt JA, Porombka D, Algermis-
sen D, Herzog S, Baumgartner W, Herden C (2008) Restricted 
expression of Borna disease virus glycoprotein in brains of 
experimentally infected Lewis rats. Neuropathol Appl Neurobiol 
34(6):590–602. https ://doi.org/10.1111/j.1365-2990.2008.00940 
.x
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
Affiliations
Friederike Liesche1  · Viktoria Ruf2 · Saida Zoubaa3 · Gwendolyn Kaletka1 · Marco Rosati4 · Dennis Rubbenstroth5 · 
Christiane Herden6 · Lutz Goehring7 · Silke Wunderlich8 · Miguel Frederic Wachter9 · Georg Rieder10 · 
Ines Lichtmannegger11 · Willibald Permanetter12 · Josef G. Heckmann13 · Klemens Angstwurm14 · 
Bernhard Neumann14 · Bruno Märkl15 · Stefan Haschka16 · Hans‑Helmut Niller17 · Barbara Schmidt17 · 
Jonathan Jantsch17 · Christoph Brochhausen18 · Kore Schlottau5 · Arnt Ebinger5 · Bernhard Hemmer8,19 · 
Markus J. Riemenschneider3 · Jochen Herms2,19 · Martin Beer5 · Kaspar Matiasek4 · Jürgen Schlegel1
1 Department of Neuropathology, School of Medicine, 
Institute of Pathology, Technical University Munich, 
Trogerstraße 18, 81675 Munich, Germany
2 Center for Neuropathology and Prion Research, Ludwig-Max
imilians-Universitaet München, Munich, Germany
3 Department of Neuropathology, University of Regensburg, 
Regensburg, Germany
4 Section of Clinical and Comparative Neuropathology, Centre 
for Clinical Veterinary Medicine, Ludwig-Maximilians 
Universitaet München, Munich, Germany
665Acta Neuropathologica (2019) 138:653–665 
1 3
5 Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, 
Greifswald-Insel Riems, Germany
6 Institute of Veterinary Pathology, Justus Liebig University, 
Giessen, Germany
7 Division of Medicine and Reproduction, Equine Hospital, 
Ludwig-Maximilians Universitaet München, Munich, 
Germany
8 Department of Neurology, Klinikum rechts der Isar, School 
of Medicine, Technical University Munich, Munich, 
Germany
9 Department of Pediatrics, Medical Faculty, Augsburg 
University, Augsburg, Germany
10 Department of Neurology, Klinikum Traunstein, Traunstein, 
Germany
11 Department of Pathology, Klinikum Traunstein, Traunstein, 
Germany
12 Department of Pathology, Municipal Hospital Landshut, 
Landshut, Germany
13 Department of Neurology, Municipal Hospital Landshut, 
Landshut, Germany
14 Department of Neurology, Regensburg University Hospital, 
Regensburg, Germany
15 Institute of Pathology, Medical Faculty, Augsburg University, 
Augsburg, Germany
16 Department of Internal Medicine II, Municipal Hospital 
Landshut, Landshut, Germany
17 Institute of Clinical Microbiology and Hygiene, Regensburg 
University Hospital, Regensburg, Germany
18 Institute of Pathology, University of Regensburg, 
Regensburg, Germany
19 Munich Cluster of Systems Neurology (SyNergy), Munich, 
Germany
